TYLER OSTLUND: Open Payments
NPI 1285335018 · VINEYARD, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,237 in 73 payments from 13 companies in 2025. Trend: 2023 $809 · 2024 $1,190 · 2025 $1,237
Food & beverage: $1,059Education: $178
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 37 | $430 |
| Janssen Biotech, Inc. | 7 | $258 |
| UCB, Inc. | 11 | $167 |
| Boston Scientific Corporation | 1 | $78 |
| Novartis Pharmaceuticals Corporation | 3 | $60 |
| Fresenius Kabi USA, LLC | 3 | $50 |
| ABBVIE INC. | 3 | $50 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| GlaxoSmithKline, LLC. | 2 | $30 |
| E.R. Squibb & Sons, L.L.C. | 1 | $24 |
Products named: TREMFYA, ENBREL, Bimzelx, KRYSTEXXA, WaveWriter Alpha Prime 16, TAVNEOS, EVENITY, COSENTYX.
Industry payments across UT — which companies pay providers there.
